Director/PDMR Shareholding

RNS Number : 8967A
CVS Group plc
28 September 2022
 

28 September 2022

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealings

CVS, one of the UK's leading providers of integrated veterinary services, announces that it was notified on 27 September 2022 that Richard Fairman, Chief Executive Officer of the Company, purchased a total of 1,177 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.

As a result, Mr Fairman's total interest in the Company, including his wife's holdings, is now 31,844 Ordinary Shares, representing 0.045% per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

 

Contacts:

CVS Group plc

Jenny Farrer Company Secretary

 

 

 

via MHP Communications

Peel Hunt (Nominated Adviser & Broker)

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

+44 (0)20 7418 8900

MHP Communications (Financial PR)

Andrew Jaques / Simon Hockridge / Rachel Farrington / Charles Hirst

+44 (0) 20 3128 8549

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Richard Fairman

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR (CEO)

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

CVS Group plc

b)

 

LEI

 

 

213800J41XDQ2NX48O05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B2863827

 

b)

 

Nature of the transaction

 

On-market purchase

c)

 

Price(s) and volume(s)

 

 

 

Price(s) - pence

 

Volume(s)

1,694.52

1,177

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

N/A - Single Transaction

 

 

 

e)

 

Date of the transaction

 

 

27 September 2022

f)

 

Place of the transaction

 

London Stock Exchange - AIM (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKNXAEKAEFA

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings